Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals  Clare Pridans,

Slides:



Advertisements
Similar presentations
Volume 1, Issue 2, Pages (February 2000)
Advertisements

Molecular Therapy - Methods & Clinical Development
Volume 19, Issue 2, Pages (February 2011)
Volume 19, Issue 1, Pages (January 2011)
Molecular Therapy - Methods & Clinical Development
Volume 15, Issue 6, Pages (June 2007)
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 3, Pages (March 2008)
Molecular Therapy - Nucleic Acids
Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation  Brile Chung, Dullei Min,
A B C Gentile et al., Figure 1A Gentile et al., Supplementary Figure 1
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy  Yuka Igarashi, Toru Uchiyama, Tomoko Minegishi, Sirirat.
Volume 17, Issue 11, Pages (November 2009)
Volume 25, Issue 3, Pages (March 2017)
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer by Andrew Wilber,
Treating Immunodeficiency through HSC Gene Therapy
Volume 17, Issue 9, Pages (September 2009)
Recent Developments in Retroviral-Mediated Gene Transduction
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Volume 14, Issue 4, Pages (October 2006)
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Neeltje A Kootstra, Ryusuke Matsumura, Inder M Verma  Molecular Therapy 
Volume 20, Issue 5, Pages (May 2012)
Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential by Amy S. Rawls, Alyssa D. Gregory,
Volume 23, Issue 5, Pages (May 2015)
Volume 10, Issue 1, Pages (July 2004)
Molecular Therapy - Methods & Clinical Development
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)‏ by Michaela Scherr, Anuhar Chaturvedi, Karin.
Volume 12, Issue 6, Pages (December 2005)
Volume 12, Issue 3, Pages (September 2005)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation  Brile Chung, Dullei Min,
Molecular Therapy - Methods & Clinical Development
Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
Volume 9, Issue 4, Pages (April 2004)
Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor  Alexander Falkenhagen, Jastaranpreet Singh, Sabah Asad, Danila Leontyev,
Generation of a stable packaging cell line producing high-titer PPT-deleted integration- deficient lentiviral vectors  Peirong Hu, Yedda Li, Mark S Sands,
Volume 15, Issue 9, Pages (September 2007)
Kailin Xu, Hong Ma, Thomas J. McCown, Inder M. Verma, Tal Kafri 
Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid Cells  Elodie Robert-Richard,
Volume 19, Issue 2, Pages (February 2011)
Volume 12, Issue 5, Pages (November 2005)
Molecular Therapy - Methods & Clinical Development
Volume 21, Issue 4, Pages (April 2013)
Volume 6, Issue 5, Pages (November 2002)
Volume 2, Issue 1, Pages (July 2000)
Volume 15, Issue 11, Pages (November 2007)
Volume 15, Issue 4, Pages (April 2007)
Production of lentiviral vectors
Volume 11, Issue 6, Pages (June 2005)
Kristoffer Weber, Udo Bartsch, Carol Stocking, Boris Fehse 
Molecular Therapy - Methods & Clinical Development
Volume 19, Issue 5, Pages (May 2011)
Volume 17, Issue 11, Pages (November 2009)
Volume 15, Issue 9, Pages (September 2007)
Molecular Therapy - Methods & Clinical Development
Volume 23, Issue 4, Pages (April 2015)
Volume 9, Issue 2, Pages (February 2004)
Volume 19, Issue 1, Pages (January 2011)
In Vivo Gene Delivery to Synovium by Lentiviral Vectors
Volume 7, Issue 3, Pages (March 2003)
Volume 21, Issue 5, Pages (May 2013)
Recent Developments in Retroviral-Mediated Gene Transduction
Molecular Therapy - Nucleic Acids
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)  Mario Amendola, Alice Giustacchini,
Volume 15, Issue 10, Pages (October 2007)
Presentation transcript:

Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals  Clare Pridans, Simon Lillico, Bruce Whitelaw, David A Hume  Molecular Therapy - Methods & Clinical Development  Volume 1, (January 2014) DOI: 10.1038/mtm.2014.10 Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Csf1r:EGFP lentiviral constructs. Schematic of murine Csf1r:EGFP constructs. All constructs contained a blasticidin-resistance gene (BSD) driven by the EM7/SV40 promoter. (a) Csf1r:EGFP-FIRE (b) Csf1r:EGFP-sFIRE (c) Csf1r:myr:EGFP-FIRE. cPPT, central polypurine tract; FIRE, Fms-Intronic Regulatory Element; ψ, HIV-1 packaging signal; LTR, long terminal repeat; RRE, rev response elements; sFIRE, short FIRE; myr, myristoylated motif. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.10) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Murine Csf1r elements in a lentivirus drive reporter gene expression in macrophages but not T lymphocytes. (a) Representative confocal microscopy images of EL4 and RAW264.7 cells transduced (n = 3) with Csf1r:EGFP-FIRE. (b) FACS analysis of RAW264.7 cells transduced with Csf1r:EGFP-FIRE or a membrane-bound EGFP (Csf1r:myr:EGFP-FIRE). (c) RAW264.7 cells transduced with (i) Csf1r:myr:mCherry-FIRE and Csf1r:EGFP-FIRE, (ii) Csf1r:myr:EGFP-FIRE, (iii) and Csf1r:mCherry-FIRE. Bar = 20µm or 10µm in C i and iii. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.10) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Csf1r:EGFP-FIRE can transduce primary rat macrophages and EGFP expression is restricted to haemopoietic cells expressing Csf1r. (a) Rat bone marrow (BM) cells were differentiated into macrophages with rhCSF1 then transduced with Csf1r:EGFP-FIRE. Bar = 50 µm. (b) Rat BM cells were cultured in interleukin (IL)-6, IL-3, and SCF and transduced with Csf1r:EGFP-FIRE, then differentiated into macrophages with rhCSF1 and images taken via confocal microscopy on days (i) 0, (ii) 3, and (iii) 7 of differentiation. (iv) A phagocytosis assay was performed on transduced macrophages. Bar = 50 µm. (c) Rat BM cells were cultured in IL-6, FLT3-L, TPO, and SCF and transduced with Csf1r:EGFP-FIRE. After 3 weeks in selection with blasticidin, cells were FACS sorted for EGFP− and EGFP+ populations. (d) mRNA was prepared from sorted EGFP− and EGFP+ populations and used in RT-PCR to analyze Csf1r expression. Each image is representative of two experiments. (e) Murine RAW264.7 cells were transduced with 1 × 105 viral titer units per 3 × 105 cells and FACS analysis performed for EGFP expression following blasticidin selection. Histogram is representative of three independent experiments. RT-PCR, reverse transcriptase PCR; SCF, stem cell factor; TPO, thrombopoietin. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.10) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 Murine Csf1r:EGFP-FIRE transduced primary macrophages from multiple species express EGFP. The following cells were differentiated into macrophages with rhCSF1 and then transduced with the lentivirus: (a) pig bone marrow–derived macrophages (BMDM), (b) cow monocyte-derived macrophages (MDM), (c) human MDM. A chicken macrophage cell line, HD11 (d) and sheep alveolar macrophages (e) were also transduced. These cells were not selected in blasticidin. Bar = 20 µm. Transductions were performed at least twice for each cell type. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.10) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions